Profil
Jan Erik Alenfall is currently the Managing Director & Director at Callipa AB.
Previously, he worked as the Chief Executive Officer & Director at DermaGen AB, Head-Research at Probi AB, Manager-International Clinical Research at Ferring Pharmaceuticals A, Associate-Clinical Research at Pharmacia AB, Head-Clinical & Preclinical Research at Trettiosjucorp AB, Manager-International Clinical Research at Rechon Life Science AB, and Head-Clinical & Preclinical Research at SkyePharma AB.
He also served as the Chief Scientific Officer at Follicum AB from 2013 to 2021.
Postes actifs de Jan Erik Alenfall
| Sociétés | Poste | Début |
|---|---|---|
| Callipa AB | Chief Executive Officer | - |
Anciens postes connus de Jan Erik Alenfall
| Sociétés | Poste | Fin |
|---|---|---|
| FOLLICUM AB (PUBL) | Chief Executive Officer | 06/04/2021 |
Ferring Pharmaceuticals A/S
 Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Corporate Officer/Principal | - |
SkyePharma AB
 SkyePharma AB Pharmaceuticals: MajorHealth Technology Part of Philip Morris International, Inc., SkyePharma AB is a Swedish company that manufactures and develops oral and inhalation products. The private company is based in Malmö, Sweden. | Corporate Officer/Principal | - |
Rechon Life Science AB
 Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Corporate Officer/Principal | - |
Trettiosjucorp AB
 Trettiosjucorp AB Pharmaceuticals: MajorHealth Technology Trettiosjucorp AB manufactures and researches on semi-solid formulations for topical use. Its products include microcid, ZALVE, hibitane, LHP, tenutex, BLOX4 and probett. The company was founded by Kare Larsson in 1984 and is headquartered in Malmo, Sweden. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROBI AB | Health Technology |
| Entreprise privées | 8 |
|---|---|
Ferring Pharmaceuticals A/S
Ferring Pharmaceuticals A/S Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals A/S specializes in the development, production and marketing of pharmaceutical products. It offers products in the fields of urology, infertility, obstetrics, gynecology, gastroenterology and maternal health. The company is headquartered in Copenhagen, Denmark. | Health Technology |
| Pharmacia AB | Health Technology |
Trettiosjucorp AB
Trettiosjucorp AB Pharmaceuticals: MajorHealth Technology Trettiosjucorp AB manufactures and researches on semi-solid formulations for topical use. Its products include microcid, ZALVE, hibitane, LHP, tenutex, BLOX4 and probett. The company was founded by Kare Larsson in 1984 and is headquartered in Malmo, Sweden. | Health Technology |
Rechon Life Science AB
Rechon Life Science AB Pharmaceuticals: MajorHealth Technology Rechon Life Science AB manufactures medicines. It specializes in aseptic injectables and sprays for nasal and oral administration. The firm's products include Iron Sucrose Injection. The firm's services include formulation and analytical development, clinical trial, stability studies, and storage and distritutions. The company is headquartered in Limhamn, Sweden. | Health Technology |
SkyePharma AB
SkyePharma AB Pharmaceuticals: MajorHealth Technology Part of Philip Morris International, Inc., SkyePharma AB is a Swedish company that manufactures and develops oral and inhalation products. The private company is based in Malmö, Sweden. | Health Technology |
Follicum AB
 Follicum AB Pharmaceuticals: MajorHealth Technology Follicum AB is a biotech company, which engages in discovery and development of peptide-based drugs. Its product pipeline include FOL-005, FOL-00X, FOL-014, and FOL-00Y which is made for stimulation of hair growth and treatment of diabetes. The company was founded by Anna Kerstin Emy Hultgårdh Nilsson and Claes Pontus Dunér on May 3, 2011 and is headquartered in Lund, Sweden. | Health Technology |
| Callipa AB | |
DermaGen AB
 DermaGen AB Pharmaceuticals: MajorHealth Technology DermaGen AB develops drugs and medical devices. It focuses on the development of topically applied products for the prevention and treatment of bacterial and fungal skin infections. The company was founded on February 2, 2004 and is headquartered in Solna, Sweden. | Health Technology |
